Stock Analysis
- China
- /
- Medical Equipment
- /
- SZSE:300298
We Think You Can Look Beyond Sinocare's (SZSE:300298) Lackluster Earnings
Shareholders appeared unconcerned with Sinocare Inc.'s (SZSE:300298) lackluster earnings report last week. We think that the softer headline numbers might be getting counterbalanced by some positive underlying factors.
See our latest analysis for Sinocare
The Impact Of Unusual Items On Profit
To properly understand Sinocare's profit results, we need to consider the CN¥116m expense attributed to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Sinocare to produce a higher profit next year, all else being equal.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Sinocare's Profit Performance
Unusual items (expenses) detracted from Sinocare's earnings over the last year, but we might see an improvement next year. Because of this, we think Sinocare's earnings potential is at least as good as it seems, and maybe even better! And the EPS is up 66% annually, over the last three years. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. For example - Sinocare has 3 warning signs we think you should be aware of.
This note has only looked at a single factor that sheds light on the nature of Sinocare's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:300298
Sinocare
Engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China.